Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer

BACKGROUND: The efficacy of neoadjuvant chemotherapy (NAC) for muscle-invasive bladder cancer (BCa) was established primarily with methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC), with complete response rates (pT0) as high as 38%. However, because of the comparable efficacy with better...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Eur Urol
Asıl Yazarlar: Zargar, Homayoun, Espiritu, Patrick N., Fairey, Adrian S., Mertens, Laura S., Dinney, Colin P., Mir, Maria C., Krabbe, Laura-Maria, Cookson, Michael S., Jacobsen, Niels-Erik, Gandhi, Nilay, Griffin, Joshua, Montgomery, Jeffrey S., Vasdev, Nikhil, Yu, Evan Y., Youssef, David, Xylinas, Evanguelos, Campain, Nicholas J., Kassouf, Wassim, Dall’Era, Marc A., Seah, Jo-An, Ercole, Cesar E., Horenblas, Simon, Sridhar, Srikala S., McGrath, Jonathan S., Aning, Jonathan, Shariat, Shahrokh F., Wright, Jonathan L., Thorpe, Andrew C., Morgan, Todd M., Holzbeierlein, Jeff M., Bivalacqua, Trinity J., North, Scott, Barocas, Daniel A., Lotan, Yair, Garcia, Jorge A., Stephenson, Andrew J., Shah, Jay B., van Rhijn, Bas W., Daneshmand, Siamak, Spiess, Philippe E., Black, Peter C.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2014
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4840190/
https://ncbi.nlm.nih.gov/pubmed/25257030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eururo.2014.09.007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller